BioNTech
Kin Cheng is an accomplished professional in the field of scientific competitive intelligence and medical insights, currently serving as Associate Director at BioNTech SE since November 2022. Prior to this role, Kin Cheng worked as a Life Sciences Consultant at PRMA Consulting Ltd from 2020 to 2022, where strategic insights were provided to major pharmaceutical clients, focusing on clinical, commercial, and market access strategies in immuno-oncology, CAR-T, and cell and gene therapy. From 2016 to 2020, Kin Cheng managed competitive intelligence and clinical development at Tessa Therapeutics Ltd, leading analysis on market trends and competitor strategies in immuno-oncology. Kin Cheng's academic credentials include a PhD in Immunology from the National University of Singapore and a Bachelor's degree in Biological and Biomedical Sciences from Monash University.
This person is not in any teams
This person is not in any offices
BioNTech
32 followers
BioNTech was founded in 2008 on the understanding that every cancer patient’s treatment should be individualized. Their vision is to provide patient-specific immunotherapies worldwide.